Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05770544
Title DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. (DETERMINE)
Acronym DETERMINE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Cancer Research UK
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries GBR

Additional content available in CKB BOOST